Distinct differences between high-grade (HGG) and low-grade gliomas (LGG) were seen with positive vessel staining for PSMA in 81% of GBM, 10% of WHO grade III and just 2% of grade II gliomas. This evidence concerns the gene FOLH1 and glioma.